| Names | |
|---|---|
| Preferred IUPAC name | (5R)-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one |
| Other names | L-ascorbic acid Vitamin C 3-Keto-L-gulofuranolactone Antiscorbutic vitamin Cevalin |
| Pronunciation | /əˈskɔːrbɪk ˈæsɪd/ |
| Identifiers | |
| CAS Number | 50-81-7 |
| Beilstein Reference | 1408053 |
| ChEBI | CHEBI:29073 |
| ChEMBL | CHEMBL50 |
| ChemSpider | 5761 |
| DrugBank | DB00126 |
| ECHA InfoCard | 100.011.278 |
| EC Number | 3.2.1.1 |
| Gmelin Reference | 87576 |
| KEGG | C00072 |
| MeSH | D001362 |
| PubChem CID | 54670067 |
| RTECS number | CI7655000 |
| UNII | PQ6CK8PD0R |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | DTXSID2023494 |
| Properties | |
| Chemical formula | C6H8O6 |
| Molar mass | 176.12 g/mol |
| Appearance | White or almost white, crystalline powder or colourless crystals |
| Odor | Odorless |
| Density | 1.65 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | -1.85 |
| Acidity (pKa) | 4.17 |
| Basicity (pKb) | 8.28 |
| Magnetic susceptibility (χ) | '−8.0×10⁻⁶ cm³/mol' |
| Refractive index (nD) | 1.645 |
| Dipole moment | 6.8 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 146.4 J·K⁻¹·mol⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -468.9 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1970 kJ/mol |
| Pharmacology | |
| ATC code | A11GA01 |
| Hazards | |
| GHS labelling | **"Not a hazardous substance or mixture according to the Globally Harmonized System (GHS)."** |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | Not classified as a hazardous substance or mixture. |
| Precautionary statements | Keep container tightly closed. Store in a cool, dry place. Avoid breathing dust. Use with adequate ventilation. Wash thoroughly after handling. |
| Flash point | 176°C |
| Autoignition temperature | 660 °C |
| Lethal dose or concentration | LD50 oral rat 11900 mg/kg |
| LD50 (median dose) | 11900 mg/kg (Rat, oral) |
| NIOSH | No NIOSH信息 |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | 85 mg |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds | Dehydroascorbic acid Erythorbic acid Ascorbyl palmitate Calcium ascorbate Sodium ascorbate Magnesium ascorbyl phosphate |
| Property | Manufacturer’s Commentary |
|---|---|
| Product Name & IUPAC Name |
Product Name: Ascorbic Acid IUPAC Name: (5R)-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one |
| Chemical Formula | C6H8O6 |
| Synonyms & Trade Names |
L-Ascorbic Acid, Vitamin C, 3-Keto-L-gulofuranolactone, Cevitamic Acid, Ascorbate (for salt forms) Commercial labeling may reflect specific grade, such as “Feed Grade Ascorbic Acid,” “Pharma Grade Ascorbic Acid,” or “Food Grade Ascorbic Acid.” Labeling is typically adjusted according to certification and application regulatory requirements. |
| CAS Registry Number | 50-81-7 |
| HS Code & Customs Classification |
HS Code: 2936.27 Ascorbic Acid falls under the heading for provitamins and vitamins, whether or not natural or reproduced by synthesis, and derivatives used mainly as vitamins. The assignment of HS Code may differ with product form (bulk, finished tableting mixture, premix), presence of stabilizing agents, or region-specific customs rules. |
Ascorbic Acid production utilizes a process that normally originates from glucose. The route selected depends on synthesis cost, environmental controls, and grade requirements. Fermentation with select microbial strains forms a key intermediate (commonly sorbose); chemical oxidation achieves lactone ring closure. Raw materials are sourced based on impurity profiles suitable to each route; analytical screening detects heavy metals and specific organic contaminants. Downstream purification uses precipitation and recrystallization, with mother liquor recirculation to reduce waste. Typical values for impurity cut-off align with application—pharmaceutical and infant nutrition applications call for higher purity and tighter in-process controls.
Visual appearance, bulk density, and particle size distribution all reflect selected purification technique and finished grade. Food and pharma grades require removal of colored impurities and odor-forming byproducts, and batch consistency is tracked via in-line spectroscopic analysis. Release of each batch is based on established internal specifications refined through ongoing process capability studies; customer audits may set more stringent limits for certain trace contaminants.
Ascorbic Acid demonstrates natural sensitivity to moisture, oxygen, light, and trace metal ions. Handling protocols and package design incorporate dehumidified air and oxygen barrier liners. Degradation rate under storage is grade- and package-dependent; nitrogen purging may be applied for certain applications demanding extended shelf life. Blending with stabilizers or coatings follows customer process requirements and influences downstream mixer compatibility and dust management during high-throughput blending.
In industrial production, ascorbic acid is commonly collected as a crystalline powder or granule, with particle size distribution depending on the intended downstream use. The color ranges from white to slightly yellowish. Bulk material should display no foreign odor. Handling bulk material during packaging and transport—especially in high humidity environments—requires careful moisture control to prevent caking or discoloration.
Melting point of ascorbic acid varies by purity and process route, but is characteristically observed before decomposition, with no boiling point under atmospheric pressure due to thermal degradation. Bulk density shifts depending on granulation and compaction method, influencing dosing equipment design and packaging selection. Flash point is not practically measurable, since the compound chars on heating rather than forming flammable vapor.
In plant processes, the main chemical vulnerability of ascorbic acid lies in its redox activity. The material is prone to oxidation, especially in the presence of metal ions, elevated temperatures, or high moisture. Stabilizer selection during formulation and antioxidant packaging in bulk shipping are dictated by the sensitivity of ascorbic acid to ambient oxygen and catalytic surfaces. Downstream degradation can lead to loss of active content, yellowing, and generation of diketogulonic acid, systematic monitoring during production, storage, and transport is standard in industry.
Solubility in purified water is high, which aligns with typical formulation usage in food, beverage, and pharmaceutical sectors. High-grade ascorbic acid rapidly dissolves in water at ambient temperature with pH-dependent behavior; precipitation and pH drift may impact sensitive applications. Solubility in organic solvents is limited; industrial users favor aqueous systems, adjusting pH and temperature based on downstream process or product requirement.
Specifications for ascorbic acid depend on customer application: pharmaceutical, food, or feed. Each industry segment defines its acceptable purity, heavy metal content, residual solvents, and foreign matter profile. Quality control releases depend on these grade-specific requirements.
Impurities in commercial ascorbic acid stem from both synthesis route and plant environment; common by-products include dehydroascorbic acid, diketogulonic acid, and residual organic or inorganic salts from process steps. The specification limits, especially for heavy metals and solvents, are linked to the target application and local regulatory authority. Regular analytical review uses validated test methods defined in current pharmacopeial and food safety standards.
Analytical methods employed for product release are validated in-house. Titration for assay, HPLC for purity and impurity fingerprinting, and trace element analysis underpin quality assurance. Standards referenced align with current editions of USP, EP, or food additive codes, per customer tier and destination market.
Industrial production requires high-purity glucose or sorbitol as starting substrate. Sourcing focuses on traceability, supply chain security, and contaminant minimization. Choice of fermentation strain or catalyst determines process viability and downstream impurity control; adjustments in raw material quality can impact yield and purification burden.
The most established route is the Reichstein process, beginning with hydrogenation of glucose to sorbitol, followed by fermentation and selective chemical conversion, leading to l-ascorbic acid. Process innovation, such as two-step fermentation, pursues higher selectivity and energy or waste minimization. Reaction pathway selection shapes downstream purification complexity, contaminant profile, and waste treatment strategy.
Key control points include monitoring of intermediate concentrations, temperature regulation, and catalyst recovery. Process impurities require stepwise removal via crystallization, filtration, or activated carbon. Advanced filtration stages and closed-system handling reduce cross-contamination risk, batch-to-batch variability, and product rejection rates.
Each batch is released based on defined critical control points covering starting material quality, process yields, impurity levels, residual solvent, and microbial limits. In-process analytical checkpoints, supported by reference methods, trigger process adjustments before final drying and sieving. Final release standard is subject to internal criteria and end-user requirements, with archived retains for complaint tracing.
Ascorbic acid demonstrates pronounced reducing ability. Practically, this allows it to participate in redox reactions for antioxidant use or as a substrate for further synthesis, such as in the production of sodium ascorbate or other salts.
Reactions such as salt formation or esterification involve controlled pH, selection of suitable base or alcohol, and exclusion of oxygen and transition metals to avoid unwanted degradation. Catalysts or solvents are chosen for process compatibility and ease of removal during purification.
Chemical modification yields products like sodium ascorbate, calcium ascorbate, or ascorbyl palmitate. Suitability for pharmaceutical or food use drives choice of precursor and process conditions; by-product management and product isolation are adjusted per derivative.
Controlling temperature and humidity in storage is critical to preserve quality. Exclusion of light and air limits oxidation; nitrogen purging and barrier-layer packaging reduce loss of active compound. Storage areas with low ambient temperature and precise climate control minimize degradation risk.
Selection of container material prioritizes impermeability to moisture and gases, chemical inertness, and mechanical protection during transit. For bulk supply, lined fiber drums or multi-layer composite bags are standard, but adaptation for customer-specific supply chains can involve bespoke containers.
Shelf life varies according to storage discipline and packaging integrity. Typical values depend on grade and application requirements. Degradation is often detected by visible discoloration, reduction in assay, or increased by-product content. Regular retest intervals form part of supplier-customer quality agreements.
Hazard classification draws from published toxicological profiles. Ascorbic acid is not classified as hazardous by routine industrial standards under GHS. Product-specific hazard communication depends on purity level, physical form (dust formation risk), and packaging size.
Key precautions focus on dust management and avoidance of contact with sources of ignition or reactive contaminants. Bulk handling in industrial facilities takes measures to control dust generation, ensure proper ventilation, and prevent prolonged exposure to high airborne concentrations.
Exposure limits, if assigned, correspond to nuisance dust regulations rather than specific toxic effects. Direct contact is avoided by using gloves and goggles in handling areas, and routine cleaning suppresses dust buildup. Chronic exposure data does not demonstrate systemic toxicity at common exposure levels for workplace safety.
Industrial ascorbic acid production globally reflects a concentrated structure. In-house process lines are scaled based on fermentation efficiency, batch yield, and conversion rates of glucose feedstocks. Facility output and inventory cycles in main producing regions such as China are directly dictated by seasonal feedstock availability, fermentation downtime, and plant maintenance schedules. Output is increasingly tied to environmental controls, particularly wastewater management and energy sourcing, which drive both operational continuity and downtime risks.
Order lead time depends on product form (pharmaceutical, food, feed, industrial grades) and on production scheduling—pharma grades or custom particle sizes require more extensive QC and often longer release windows. Bulk orders for major distributors will see lead times pegged to current batch release status and on outbound logistics. Minimum order quantities can vary: industrial and food grades shipped in bulk can fill FCL or LCL containers; specialized grades or packaging options (low-moisture, specific granulation) call for negotiation.
Available configurations span kraft paper bags with PE liners, fiber drums, and composite packaging with moisture-protective barriers for high-purity and pharma applications. Typical selections depend on grade—feed and technical grades use bulk inner PE, while food and pharma grades utilize multi-layered barrier films with nitrogen flush options for oxidative stability. Each packaging format’s physical strength directly affects transit loss, shelf stability, and ease of warehouse stacking.
Standard commercial practice in the industry sees Ex-Works, FOB, and CIF as primary shipping terms, driven by port access, customer preference, and buyer’s own customs-clearance experience. Payment typically operates on T/T (Telegraphic Transfer) or L/C (Letter of Credit), especially for high-volume or export contracts. Regulatory certifications and destination import requirements may extend documentation needs, impacting clearance and effective delivery time.
The cost structure behind ascorbic acid relies on glucose (main feedstock), fermentation media, process chemicals, utilities (energy, steam, cooling water), downstream extraction reagents, and QC labor. Glucose price, which tracks agricultural corn output and sugar conversion ratios, forms the largest raw material input by cost. Production grades with enhanced purification, higher optical purity, or stricter impurity profiles incur incremental costs from additional solvent use, extended column chromatography, and higher in-process rejection rates.
Corn price fluctuations, shifts in transport energy prices, changes in regulatory enforcement regarding waste and emissions, and periodically shifting export tariffs from producing countries drive the largest month-to-month swings. Plant maintenance cycles, especially those mandated by stricter environmental policies or unforeseen shutdowns, can induce capacity bottlenecks and sharp price moves. Exchange rate shifts between RMB, USD, and euro, and unplanned policy interventions (quotas, anti-dumping duties) directly push supplier cost bases and resulting offer prices.
Finished product pricing reflects QC-driven segregation by purity (USP/EP/JP, FCC, feed, antioxidant, or industrial grades), impurity limits (heavy metals, residual solvents, byproducts), and validation for specific markets (halal, kosher, GMP-certified). Additional surcharges hit orders demanding specialized packaging or documentation for regulated markets.
Grades targeting pharmaceutical APIs demand tighter release protocols—microbial, pyrogen, and heavy metal control rescreening—raising direct and indirect costs. Food grade may relax on impurity profile but still require batch-specific allergen controls, while industrial grades, focused on antioxidant application, permit wider content variation and simpler packaging but often run on older process lines. Packaging certified for migration-resistance or pharma usage, particularly those requiring double sealing or foil lining, leads to higher per-kg cost.
The global ascorbic acid market sources a significant portion from integrated Chinese producers, with limited capacity extension outside East Asia. US and EU plants generally focus on food/pharma verticals with smaller batch volumes and higher regulatory overheads. Markets in India and Japan emphasize local formulations often importing bulk for final conversion.
US and EU buyers import bulk or packaged product, balancing strict non-GMO and allergen traceability with premium certification requirements. Regulatory oversight, such as USP/FCC/EP compliance, drives up cost. Japanese users historically set unmatched specs for food/personal care. China’s dominance reflects lower upstream glucose cost and large-scale fermentation, but supply gets periodically disrupted by local policy shifts. Indian demand surges in feed and formulated supplement, sometimes leading to strong spot premium volatility.
Based on current upstream agricultural input forecasting and fermentation technology improvements, steady pressure to optimize output per batch is expected to limit significant upward price movement. Tightening of environmental controls, especially in Chinese industrial zones, poses a risk for temporary capacity curtailment and price surges if farmland or water-use restrictions accelerate. Regulatory alignment between the EU and US could push a premium for traceable and certified batches, maintaining higher price bands for pharma and food grades through 2026.
Industrial sourcing analytics, global trade statistics, in-house batch costing, and contract pricing feedback from direct export customers provide the foundational pricing and capacity model. Market movements incorporate both spot and term contract data, harmonized with upstream input price tracking.
Major Chinese producers have undergone environmental audits in the past year, resulting in sporadic supply disruptions tied to compliance mandates. Market participants have noted periodic price jumps during these phases, with downstream impact on global distributors and direct users. New plant start-up projects have faced longer qualification periods due to stricter safety and validation requirements, extending time-to-market.
EU REACH and US FDA rules for food and pharmaceutical input grades continue to evolve, increasing documentation and traceability overhead. Stricter enforcement of maximum impurity levels, including heavy metals and process byproducts, has forced some older plants to retrofit with new automation or monitoring, driving up operation costs but improving release consistency. Halal, kosher, and allergen-free certificates are increasingly demanded in international tenders, requiring upstream raw material risk control.
Long-term mitigation strategies include diversification of glucose supply, investment in in-house waste treatment and water recycling, and process automation designed for tighter product traceability. Batch record digitization and compliance with global audit standards support both regulatory access and rapid response to sudden market changes. Flexibility in packaging and shipping, inclusion of new DAP/DDP terms for major customers, and partnership with logistics providers allow for continuity even during market volatility.
The industrial landscape for ascorbic acid shifts depending on sector priorities. In food processing, ascorbic acid works as an antioxidant to protect freshness in processed meat, beverage, and bakery sectors. Pharmaceutical processors integrate it for both vitamin supplement tablets and parenteral formulations. In cosmetics, formulators target skin-lightening and anti-aging benefits. Technical and industrial applications include polymer stabilization and as an inhibitor for metal corrosion.
| Industry | Typical Grade(s) | Common Purity Range | Distinctive Grade Features |
|---|---|---|---|
| Food & Beverage | Food Grade, FCC / E300 | Specified according to food additive requirements | Regulatory traceability, verified food-safe excipients, allergen controls |
| Pharmaceutical | USP / EP / JP / BP | Controlled to compendial specifications | Complying with global monographs, bioburden and endotoxin controls |
| Cosmetics | Cosmetic Grade, sometimes Food/Pharma Grade | Consistent with end-use formulation requirements | Controlled impurity content, micro profiles suited for topical applications |
| Industrial/Technical | Technical Grade | Fewer regulatory parameters | Cost-sensitive, broader acceptance of impurity spectrum |
Start with a clear process map: Is the aim direct human consumption, external application, or indirect technical use? Internal teams in production, quality, and regulatory evaluate the process end-point before aligning with possible grades from qualified lines.
Each sector faces region-specific rules. Food and pharma require input from regulatory affairs based on the final product’s geography and legal distribution channel. Meeting label claims and maintaining audit trails from source batch to finished product differentiates compliant production lines.
Process engineers and QC determine minimum acceptable impurity levels. For food and pharma, acceptance limits derive from toxicological data, process cross-contamination risks, and the medical or dietary role of vitamin C. Cosmetic and technical buyers may choose less refined lots if their process tolerates the impurity profile.
Production planning balances batch size with lead time and inventory costs. High-purity grades involve added purification and documentation steps, reflected in cost structures and supply capacity. Large-volume users coordinate with scheduling to match output with demand spikes.
Laboratory and pilot production setup verify particle flow, dissolution, compatibility with process aids, and reaction with excipients or base ingredients. Independent QA teams ensure a batch meets spec before approving the main order, using both in-house analytics and, as needed, third-party validation.
An experienced manufacturer links raw material procurement with multi-step purification based on historical performance of each upstream supplier. Each route (e.g., sorbitol oxidation, Reichstein, or two-step fermentation) brings differences in byproduct spectrum and color formation. Key control points target decolorization, trace metal removal, and microbial filtration. Continuous batch analytics check for off-spec formation before final blending and packing.
Release standards respond to both internal statistical quality control and end-user validation data. Salient characteristics—like particle morphology, bulk density, and dustiness—get fine-tuned using equipment data and field feedback. Responsible manufacturers update batch records with cross-links to each QC checkpoint, building confidence in downstream process performance.
In chemical manufacturing, regulatory alignment forms the underpinning of trustworthy ascorbic acid supply. Our production units meet the prerequisites of quality management systems with established third-party audit histories. Each production line maintains traceability, and all process validation occurs in alignment with documented control points set by internationally recognized standards. Audit findings prompt direct feedback to continual improvement cycles. Specific certifications, such as ISO 9001 for general quality management and ISO 22000 for food safety management, apply per plant and per production route, tracked by both local jurisdiction and customer audit results. These certifications remain process-route-dependent, acknowledging plant-specific variations in raw material handling, cleaning protocol, and record retention.
Certifiable attributes for ascorbic acid originate in source materials and isolation steps matched to the intended usage—pharmaceutical, food, or feed grade. Product-specific certifications require documentation at each stage, including allergen declarations, trace contaminant reports, and process residual summaries. Halal and Kosher compliance certifications reflect batch-level segregation. Non-GMO and allergen-free statements reflect supply chain documentation and regular cross-contamination audits. The breadth of certification is tailored to the grade and customer segment (e.g., food, pharma, industrial), not a uniform blanket across all SKUs.
A full technical dossier accompanies every lot upon request, detailing raw material origins, production batch history, and final analytical results. Routine CofA (Certificate of Analysis) data present batch-specific impurity profiles mapped to grade release criteria. Regulatory compliance certificates—such as Reach or US FDA DMF—are available contingent on grade qualification and customer agreement. Specifications and supporting safety data sheet documentation reflect both current internal QC criteria and the latest regulatory requirements for the shipment region. Customers requesting tailored documentation for novel applications or specific regulatory reviews engage directly with the quality department for process-level records and stability data as needed.
Production scale-up strategies rely on parallel line redundancy and advanced material sourcing contracts. Our plant scheduling system prioritizes key accounts to buffer seasonal demand fluctuation and sales agreement obligations. Capacity reserve for large orders is possible through rolling production planning, guaranteeing fulfillment continuity even during raw material supply swings. Long-term cooperation agreements with strategic customers grant priority status in plant slot allocation, and enable volume-based flexibility for high-turnover partners expecting dynamic order sizing.
Core manufacturing capacity builds from sustained capital investment in line upgrades, raw material contracting, and predictive maintenance. Trend reviews of annual output inform capex decisions that expand debottlenecking and raise throughput per line when customer forecasts justify additional supply. Our real-time inventory integration with logistic partners ensures stable on-hand supply through advanced stock management. Buffer stocks and safety stock policy derive from market segment volatility and regional distribution risk, not a fixed generic inventory ratio.
Sample support operates through direct interface with technical service staff. Evaluation quantities are released upon request, with material origin, batch number, grade, and analytical report provided for conformity assessment. Formal sample orders follow simplified procedures for existing partners with in-place supply contracts, while new partners undergo basic qualification checks, including intended use alignment and regulatory requirement declaration. Sample shipping leverages temperature and packaging options specific to grade stability or shelf life concerns. Technical follow-up accompanies every initial evaluation to ensure the sample meets practical downstream process needs.
Business cooperation adapts to fluctuations in global raw material supplies, international logistics, and end-user project cycles. Short-cycle spot purchases co-exist with fix-term contract options. Manufacturers and high-volume blenders may draw from framework agreements that balance fixed pricing, forecast-based calls, and regular delivery intervals. For customers undergoing project transitions, standby delivery blocks and split shipments help manage risk without over-committing inventory. Each negotiation considers lead time tolerance, customs clearance burdens, compliance document needs, and packaging format preferences. The model adapts in real-time, subject to upstream input cost pressures and regulatory changes, always with direct technical support for application- or compliance-driven modifications.
Most laboratories and production sites focus on yield improvement, impurity control, and process integration. Technical teams scrutinize fermentation routes, working on strain improvements to drive biosynthetic efficiency. Chemical process engineers concentrate on reducing byproducts tied to batch yields, since even minor precursors cause downstream purification challenges. Quality assurance groups review every lot for trace contaminants, seeking both cost reduction and more reliable purification.
Grades intended for injection, food, and feed each drive their own R&D programs. Pharmaceutical-grade material requires lower residual solvent levels and tighter control of metal impurities. Feed and food applications leverage process tweaks that target bulk production efficiency and lower production energy requirements, without lowering critical parameters.
Formulators and industrial users explore ascorbic acid for antioxidant roles far outside the traditional beverage and supplement sectors. Trends include stabilizing polymer resins, new roles in battery chemistries, and reducing agents in metal surface treatments. In these cases, technical teams tailor grade and particle profile to permit smoother downstream processing, since physical attributes affect mixing and solubility in large-scale operations.
Maintaining stability during bulk storage and distribution remains a challenge, especially in high humidity zones. Production lines continue to struggle with powder caking in large drums, driving investments in packaging technology and anti-caking agents, especially for customers requiring large volumes.
Some breakthroughs in process route modification have lowered precursor impurity admixture, permitting more selective crystallization and reducing the filter load at isolation. The trend toward continuous processing instead of traditional batch crystallization shows promise, with in-line monitoring systems catching deviations in real time before full batch losses can occur.
Bulk vitamin C demand grows in alignment with processed foods, supplements, and animal feed. Feed sector buyers are increasing, with demand moving from North America and Europe toward Asia-Pacific. Industrial applications for antioxidants in polymers and metalworking chemicals are driving modest new demand segments.
Spot price volatility persists; regions with greater access to starch-based raw materials and reliable utilities infrastructure hold a significant cost edge. Trade and tariff pressures affect risk planning and supply chain reliability, emphasizing the need for flexible logistics and multiple packaging formats.
Fermentation techniques continue to evolve. Engineering teams adopt more robust microbe strains to boost process tolerance and lower sensitivity to upstream substrate variation. Routine deployment of advanced process controls enhances lot traceability and rapid deviation detection, crucial for pharmaceutical and food clients.
Plant upgrades in solvent recovery, waste minimization, and energy integration remain critical. Teams design each technical step to target reproducibility in color, ash content, and solubility to meet the different grade specs demanded by high-end food processors or injectable preparation customers.
Environment teams push for tightened water recycling, acid recovery, and lower air emissions during synthesis and purification. Ongoing projects address energy balance optimization, with heat recovery and minimal solvent loss.
Raw material selection favors renewable carbohydrate sources, evaluated not only for chemical purity but also for local supply consistency. Technologists reviewing green chemistry metrics balance waste generation, utility intensity, and lifecycle product impacts, since market certification increasingly depends not only on analytical compliance but also on documented sustainability practices.
Technical support specialists review each customer’s application requirements, advising on grade selection, particle attributes, and potential interaction with process equipment. Consultation extends to troubleshooting dissolution kinetics during scale-up and process validation for pharmaceutical manufacturers.
Field engineers assist with scale-up validation, especially where solubility and blend uniformity affect batch reproducibility. Feed and food producers working with automated dosing systems require regular compatibility checks, with support teams analyzing possible flow or caking issues under both humid and dry conditions.
Process engineers also provide guidance on impurity fingerprint analysis, working closely with customers who face regulatory change or internal lot-release adjustments. For custom projects, small-batch pilot lots are arranged pre-production, allowing direct evaluation under client-specific process conditions.
Quality teams maintain lot records, with documentation traceable back to raw material intake and every intermediate process step. Any reported issue triggers a batch investigation, with corrective action grounded in production and lab data. Return and exchange policies operate according to agreed technical specs and customer feedback, reflecting typical industry batch acceptance standards for vitamin C.
Supply continuity planning uses dual-plant strategies and flexible pack size offerings to ensure steady delivery, particularly to clients with strict inventory control demands or lean inbound supply chains. Technical service lines remain open for rapid response to product quality, application, or process-change inquiries.
As a direct producer of ascorbic acid, our focus remains on each stage of the production process. We manage everything from sourcing raw glucose to final crystallization and drying, using a continuous process line that enables oversight and adjustment in real time. Rigorous filtration and purification remove trace impurities, maintaining the chemical profile required for high-volume food, beverage, and pharmaceutical sectors.
Ascorbic acid serves as a vital ingredient throughout industries. Food manufacturers use it to prevent oxidative spoilage in fresh-cut produce and processed meats. Beverage plants depend on our fine ascorbic acid to retain color and taste stability in juices and sport drinks. Pharmaceutical companies specify our product for its role in stable vitamin supplement forms and injectable preparations. Animal feed processors value ascorbic acid to support livestock nutrition. Every application calls for batch consistency and clear supportive documentation, both of which we control internally through validated process protocols.
In-plant laboratories test each run in accordance with established pharmacopeia and food additive standards. Our specialists measure particle size, assay value, trace metals, and moisture to ensure conformity across shipments. A robust traceability system links every lot to production records, including raw material origin and processing batch data. This focus on traceable control reduces batch-to-batch variability and supports our customers’ internal compliance and downstream quality checks.
Automated packaging lines handle primary and secondary packaging formats suitable for bulk handling and ingredient blending. We pack ascorbic acid in multi-layer kraft drum systems and high-barrier inner liners to protect from moisture and oxygen, crucial for shelf life and flowability. Palletized shipments accommodate both domestic and international transport modes, and integrated ERP lets us align lot numbering and packaging labels to customer SCADA or warehouse systems.
Our technical team responds directly to scaling, blending, and processing questions from industrial buyers. We support formulation teams with detailed particle analysis, solubility profiles, and mixing behavior studies. Our production engineers assist customers managing in-line dosing or continuous blending, reviewing data to reduce production downtime and minimize ingredient waste.
Producers requiring reliable ingredient supply benefit from integrated process control and documented supply chains. Distributors servicing multiple end-user segments gain logistical flexibility; we offer consolidated loads and split shipments. Procurement teams valuing reliable lead times and responsive order tracking work directly with in-house logistics. Our approach reduces the risk of ingredient shortage and unexpected process disruption, supporting continuity in industrial production lines.
At our manufacturing facility, we focus on the reliability and consistency of our ascorbic acid (vitamin C) output. Our production team draws on decades of technical experience refining the fermentation and crystallization processes to ensure the quality meets expectations for food, feed, and pharma customers alike.
We set our minimum assay at 99.0% pure ascorbic acid, calculated on a dry basis. This target reflects both the demands of end users and the realities of global pharmacopeial requirements. From the point of dry-crystallizing the product, our operations maintain robust controls to reduce impurities and limit residual moisture, keeping the purity high and consistent with internationally accepted benchmarks.
Technical audits and customer reviews consistently reinforce the importance of this high assay threshold. Customers in beverage, supplement, and food processing sectors require a predictable and stable ingredient for reactive blending, sensitive flavor profiles, and regulated labeling. Pharmaceutical partners depend on clearly documented assay values when preparing injections, tablets, or bulk blends.
Our lab team uses titration with 2,6-dichlorophenolindophenol (DCPIP) solution as our main assay method for ascorbic acid. This approach is officially recognized in the current Food Chemicals Codex, United States Pharmacopeia, and European Pharmacopoeia. The method centers on the reduction of the DCPIP reagent by ascorbic acid, resulting in the decolorization of the dye.
We run all batch reports using this titration method, which offers straightforward repeatability and gives technical staff clear insight into batch consistency. This method remains robust even when working with fine powders or granular forms, and our team calibrates equipment regularly to detect small deviations that could affect large-scale formulation. We do not rely on theoretical calculations; every production lot undergoes direct assay measurement in our in-house lab, with cross-checks for accuracy.
Through years of cooperation with QA teams at multinational production sites, we see that a clearly defined analysis method shortens technical validation cycles and removes uncertainty in regulatory submissions. End users do not have time for guesswork: clear titles, well-documented protocols, and consistent data formats ensure raw material qualification proceeds without unnecessary re-testing or rework.
We welcome plant audits and regularly share detailed batch records, including assay values and titration protocols, with authorized customers. This transparency builds trust, shortens approval timelines, and lowers the risk of supply chain interruptions. Our technical service team regularly reviews and updates internal SOPs to reflect changes in pharmacopeial guidance and to incorporate feedback from our most demanding clients.
Improvements in production and analysis are ongoing. We continually review new instrumental methods such as HPLC or UV spectrophotometry, especially where customers ask for more granular impurity profiles or additional traceability documentation. Our process engineers and analysts consult with customers to align on technical requirements, and we provide additional certificates or documentation where requested.
Producing high assay ascorbic acid takes more than an equipment investment; it relies on operator training, robust audit trails, and constant communication between production and QC. Our team believes detailed, accurate, and defensible purity information helps our customers reduce downstream risks, speed new product launches, and maintain compliance in their own markets.
Running a chemical manufacturing plant means organizing everything from sourcing raw materials to shipping finished products by the ton. Our team hears questions almost every day about minimum order quantities (MOQ) and turnaround time. Decisions on batch size and shipment date come from experience in production scheduling and years of shipping ascorbic acid to food, pharma, and industrial businesses worldwide.
In chemical manufacturing, MOQ comes down to efficiency. Producing ascorbic acid on an industrial scale involves dedicated production lines, cleaning cycles, and allocation of packing resources. To run our plant efficiently and keep product quality consistent, we set our standard MOQ for export orders based on one full pallet. That’s 500 kg, usually packed in 25 kg fiber drums or as required in strong, double-liner cartons.
Some buyers need ten or twenty metric tons, filling full container loads for regular supply chains. Others run smaller blending or repackaging operations and go for single-pallet quantities. Both scenarios line up with our production batches, provided the order meets the threshold for direct factory shipping. MOQs prevent half-filled batches or excess change-over, which slows down quality control and increases waste.
Production timelines for ascorbic acid depend on batch frequency and current orders in our system. During busy seasons—especially before holidays or crop protection campaigns—orders fill the production slots. On average, our plant schedules new ascorbic acid orders within 10–20 days after contract confirmation and payment receipt. Shipping time depends on port schedules and location but typically falls into predictable cycles for our global clients.
Factory-direct orders gain a clear advantage here. Our plant controls the whole process, from fermentation to purification, drying, and packaging. Our technical team oversees the batch integrity and process records. Quality assurance teams finalize release documents before any shipment. This direct link between production and customers keeps timelines reliable and transparent. We don’t wait for upstream allocation or third-party clearance.
Every ton of ascorbic acid leaving our warehouse carries a batch record and certificate of analysis tied to in-house tests and periodic third-party audits. When a regular contract calls for monthly delivery of set quantities, we add those into advance production cycles, which helps shorten lead time. For urgent or custom-packed shipments, express processing is possible with an additional rush fee. The key is coordination—early notice gives us more room to synchronize manufacturing with international shipping timetables.
Some clients need pharma-grade ascorbic acid and request extra analytical data. Our laboratories can provide detailed particle size distribution, heavy metal testing, and even specific certificates. These requests require a little more preparation time, but we always communicate the expected schedule before contract signature.
For over two decades, we’ve supplied ascorbic acid to buyers with deadlines to meet and strict regulatory regimes to satisfy. Our customer service comes from factory managers—not brokers. Every question about order size or expected ship date gets a direct answer, rooted in what our plant can deliver. Whether the order is a few pallets or a dozen containers, reliability comes from our in-house production team and direct shipment, every time.
As a primary manufacturer of ascorbic acid, every step we take starts with compliance. Our production lines consistently follow the regulatory frameworks laid out by food and pharmaceutical authorities, both domestically and internationally. The focus stays sharp on every aspect of current Good Manufacturing Practice (cGMP), as detailed by the United States Food and Drug Administration and reinforced by the European Pharmacopoeia and the Food Chemicals Codex. These standards dictate everything from raw material sourcing to finished batch release.
To meet these strict requirements, our quality control team audits every batch using validated analytical methods and up-to-date test instruments. Certificates of Analysis for each lot confirm purity, assay, loss on drying, and microbiological parameters comply with regulatory monographs. These data aren’t just paperwork—they reflect the real output of our process and mirror our day-to-day lab records.
We understand how food and pharma manufacturers expect nothing less than full traceability. Our ascorbic acid adheres to relevant sections of FDA 21 CFR, European Union Directives, and increasingly, to Chinese and Indian pharmacopoeia standards. Our facilities regularly undergo independent third-party audits for ISO 9001 and FSSC 22000, ensuring that customers in regulated markets receive compliant product for direct or formulated use.
Documentation is more than formality in today’s cross-border logistics environment. On request, we issue Halal and Kosher certificates, allergen statements, BSE/TSE declarations, and GMO-free guarantees. We also maintain full documentation on origin of raw materials, making country of origin declarations straightforward for import authorities.
International shipments move with a complete suite of shipping and customs paperwork. Each order leaves our facility packed with batch-specific Certificates of Analysis, Material Safety Data Sheets compliant with GHS, and signed declarations of compliance with the applicable regulatory standards for food or pharma use.
Our export documents include invoice and packing lists in the requested formats, Certificate of Origin, and other trade-specific certifications where needed. For pharmaceutical customers, we supplement the dossier with a TSE/BSE-free statement and supply documentation supporting compliance with DMF (Drug Master File) filings recognized by authorities in the US, Europe, and select Asian markets.
Although regulatory demands evolve, our documentation team works with dedicated specialists to interpret and implement any new customs or compliance requirements. We track changes in global food additive and pharmaceutical ingredient rules so shipments avoid unnecessary delays at borders.
Investing in analytical capabilities, staff training, and updated documentation systems keeps us positioned to meet new regulatory challenges. We welcome audits and regulatory queries at any stage in the relationship, providing transparent documentation and open access to our production process records in line with customer and authority expectations.
Years of experience in direct exports have shown us that proactive communication and consistently maintained records form the backbone of reliable international supply. Any customer requiring additional regulatory support or documentation detail can engage directly with our technical and export teams—no third parties involved. As the direct manufacturer, we provide real answers backed by first-hand data, all generated within our own production and compliance operations.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
